NDC 53002-2322
Clindamycin hydrochloride 150 mg capsule
On the label: RPK Pharmaceuticals, Inc.. It's repackaged: RPK Pharmaceuticals, Inc. rebottles it from Caraco Pharmaceutical Laboratories, Ltd.'s NDC 63304-692.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Ohm Laboratories Inc. | North Brunswick, NJ, United States | Makes it | No problems foundOct 31, 2024 · 22 inspections |
| Sun Pharmaceutical Industries Limited | Halol, India | Makes it | Serious problems, FDA actionJun 13, 2025 · 12 inspections, 5 with FDA action |
Repackaging site
- RPK Pharmaceuticals, Inc., Union City, California, United States · repackages it and relabels it
Recalls
- Mar 15, 2021 · Class II · Cardinal Health Inc.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots: AB77104
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Clindamycin: every company that makes it
- Form
- capsule
- Strength
- 150 mg
- Approval
- ANDA ANDA065061
- On the market since
- Mar 23, 2001
- Package NDCs
53002-2322-053002-2322-153002-2322-253002-2322-353002-2322-453002-2322-553002-2322-653002-2322-853002-2322-9- Official label
- DailyMed (National Library of Medicine), updated Sep 11, 2023
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?